What we offer
We offer expertise across all major asset classes, with investment teams situated around the world
Equities
We offer a wide range of equity strategies encompassing different geographic focuses and investment styles. The teams include those with a global perspective, those with a regional focus – Europe, US, Asia Pacific and Emerging Markets – and those invested in specialist sectors. A range of growth, value and absolute return styles are employed. These teams generally apply processes based on fundamental research and bottom-up stock picking.
Equities
in assets under management*
Equity Perspectives
Insights from our equity team to help clients navigate the risk and opportunities
Fixed income
Our Fixed Income teams provide coverage across the asset class, applying a wide range of differentiated techniques. These teams include those adopting global unconstrained approaches through to those with more focused mandates. The capabilities of these teams can be accessed through individual strategies and are combined where appropriate to form multi-strategy offerings.
Fixed income
US$59.8bn in assets under management*
Fixed Income Perspectives
Quarterly insight from our fixed income teams to help clients navigate the risks and opportunities ahead.
Alternatives
The Janus Henderson Alternatives grouping includes teams with different areas of focus and approach. The Diversified Alternatives Team brings together a cross-asset class combination of alpha generation, risk management, and efficient beta replication strategies. These include multi-strategy, liquid alternatives, agriculture, and global commodities/managed futures.
Alternatives
US$10.7bn in assets under management*
Multi-asset
Janus Henderson Multi-Asset includes teams in the US and UK. In the US, our teams manage US and global asset allocation strategies. In the UK, we have asset allocation specialists, traditional multi-manager investors, and those focused on alternative asset classes.
Multi-asset
US$45.5bn in assets under management*
*As at 31 December 2022
Latest insights
Global Perspectives: Why biotech could be embarking on a new decade of growth
A wave of innovative therapies is beginning to hit the market, transforming the prospects of the biotech firms behind the science.
Read more
Do fund flows affect market prices?
Is there a statistical relationship between fund flows and market price moves?
Read more
Investment opportunities from late-cycle shocks and surprises?
Paul O’Connor, Head of the UK-based Multi-Asset Team, considers recent uncertainty in the US and European banking sectors in the context of a broader late-cycle environment.
Read more